{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:32:15Z","timestamp":1793295135194,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/25\/N\/NZ5\/02689"],"award-info":[{"award-number":["2017\/25\/N\/NZ5\/02689"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.advms.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T13:09:12Z","timestamp":1606396152000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic value of late gadolinium enhancement mass index in patients with pulmonary arterial hypertension"],"prefix":"10.1016","volume":"66","author":[{"given":"Remigiusz","family":"Kazimierczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz A.","family":"Ma\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Szumowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"B\u0142aszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Jurgilewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"H\u0142adu\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Sobkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"My\u015bliwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Grzywna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u0142odzimierz J.","family":"Musia\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol A.","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2020.11.002_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.advms.2020.11.002_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/thoraxjnl-2015-207170","article-title":"The molecular targets of approved treatments for pulmonary arterial hypertension","volume":"71","author":"Humbert","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.advms.2020.11.002_bib3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2008.08.033","article-title":"Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension","volume":"52","author":"Benza","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.advms.2020.11.002_bib4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1183\/09031936.00139907","article-title":"Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension","volume":"33","author":"McLure","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.advms.2020.11.002_bib5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCULATIONAHA.106.674028","article-title":"Comprehensive invasive and noninvasive approach to the right ventricle pulmonary circulation unit: state of the art and clinical and research implications","volume":"120","author":"Champion","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.advms.2020.11.002_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmri.22011","article-title":"Measuring the heart in pulmonary arterial hypertension (PAH): implications for trial study size","volume":"31","author":"Bradlow","year":"2010","journal-title":"J\u00a0Magn Reson Imag"},{"issue":"4","key":"10.1016\/j.advms.2020.11.002_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.advms.2020.11.002_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ehf2.12201","article-title":"Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis","volume":"5","author":"Smedema","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.advms.2020.11.002_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiol.2018172435","article-title":"Left ventricular myocardial deformation on cine MR images: relationship to severity of disease and prognosis in light-chain amyloidosis","volume":"288","author":"Wan","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.advms.2020.11.002_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.amjcard.2007.03.094","article-title":"Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension","volume":"100","author":"Sanz","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.advms.2020.11.002_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1259\/bjr\/28241773","article-title":"Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: evaluation by cardiac MRI","volume":"82","author":"Junqueira","year":"2009","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.advms.2020.11.002_bib12","first-page":"CRCM","article-title":"Does late gadolinium enhancement still have value? Right ventricular internal mechanical work, Ea\/emax and late gadolinium enhancement as prognostic markers in patients with advanced pulmonary hypertension via cardiac MRI","volume":"2017","author":"Abouelnour","year":"2017","journal-title":"Cardiol Res Cardiovasc Med"},{"key":"10.1016\/j.advms.2020.11.002_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2214\/AJR.09.4114","article-title":"Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling","volume":"196","author":"Shehata","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.advms.2020.11.002_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2214\/AJR.05.1259","article-title":"Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension","volume":"188","author":"McCann","year":"2007","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.advms.2020.11.002_bib15","doi-asserted-by":"crossref","first-page":"66724","DOI":"10.1371\/journal.pone.0066724","article-title":"Paradoxical interventricular septal motion as a major determinant of late gadolinium enhancement in ventricular insertion points in pulmonary hypertension","volume":"8","author":"Sato","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2020.11.002_bib16","first-page":"83","article-title":"Validation of performance of free of charge plugin for the open-source platform to perform cardiac segmentation in magnetic resonance imaging","volume":"3","author":"Szychta","year":"2018","journal-title":"Heartbeat"},{"issue":"1","key":"10.1016\/j.advms.2020.11.002_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12968-016-0258-x","article-title":"Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking","volume":"18","author":"de Siqueira","year":"2016","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"19","key":"10.1016\/j.advms.2020.11.002_bib18","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/eurheartj\/ehi328","article-title":"Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension","volume":"26","author":"Blyth","year":"2005","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.advms.2020.11.002_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/CIRCIMAGING.109.919779","article-title":"Understanding late gadolinium enhancement in pulmonary hypertension","volume":"3","author":"Bradlow","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.advms.2020.11.002_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0735-1097(01)01496-6","article-title":"Right ventricular ischemia in patients with primary pulmonary hypertension","volume":"38","author":"G\u00f3mez","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.advms.2020.11.002_bib21","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jcmg.2018.12.032","article-title":"Cardiac magnetic resonance imaging-based right ventricular strain analysis for assessment of coupling and diastolic function in pulmonary hypertension","volume":"12","author":"Tello","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.advms.2020.11.002_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10554-015-0787-7","article-title":"Increased native T1-values at the interventricular insertion regions in precapillary pulmonaryhypertension","volume":"32","author":"Spruijt","year":"2016","journal-title":"Int J Cardiovasc Imag"},{"issue":"suppl_1","key":"10.1016\/j.advms.2020.11.002_bib23","article-title":"P1630 Myocardial late gadolinium enhancement mass and FDG uptake assessments using a hybrid PET\/MRI system in patients with pulmonary arterial hypertension [abstract]","volume":"39","author":"Kazimierczyk","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.advms.2020.11.002_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1532-429X-14-11","article-title":"Late gadolinium enhancement cardio- vascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension","volume":"14","author":"Freed","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"12","key":"10.1016\/j.advms.2020.11.002_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jcmg.2014.08.014","article-title":"LGE patterns in pulmonary hypertension do not impact overall mortality","volume":"7","author":"Swift","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.advms.2020.11.002_bib26","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"van Wolferen","year":"2007","journal-title":"Eur Heart J"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112620300420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112620300420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:40:22Z","timestamp":1761824422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112620300420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1896112620300420"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2020.11.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of late gadolinium enhancement mass index in patients with pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}